A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a Next-Generation Propellant in Participants 40 to 80 Years of Age With COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

297

Participants

Timeline

Start Date

January 11, 2024

Primary Completion Date

August 12, 2025

Study Completion Date

August 12, 2025

Conditions
COPD (Chronic Obstructive Pulmonary Disease)
Interventions
DRUG

BGF MDI HFO 320/14.4/9.6μg

Study interventions will be administered orally via MDI as 2 inhalations BID (every morning and evening, approximately 12 hours apart)

DRUG

BGF MDI HFA 320/14.4/9.6 μg

Study interventions will be administered orally via MDI as 2 inhalations BID (every morning and evening, approximately 12 hours apart):

DRUG

Placebo MDI HFA

Study interventions will be administered orally via MDI as 2 inhalations BID (every morning and evening, approximately 12 hours apart)

Trial Locations (87)

1000

Research Site, Quezon City

1202

Research Site, Sofia

1742

Research Site, Las Piñas

1756

Research Site, Sofia

2000

Research Site, Rosario

2300

Research Site, Pernik

2660

Research Site, Balassagyarmat

3000

Research Site, Vratsa

4002

Research Site, Plovdiv

4080

Research Site, Hajdúnánás

4150

Research Site, Püspökladány

5000

Research Site, Veliko Tarnovo

Research Site, Iloilo City

5800

Research Site, Pleven

7635

Research Site, Pécs

8000

Research Site, Burgas

9000

Research Site, Varna

9200

Research Site, Mosonmagyaróvár

10000

Research Site, Hanoi

10450

Research Site, George Town

10455

Research Site, The Bronx

19114

Research Site, Philadelphia

20400

Research Site, Kuala Terengganu

22000

Research Site, Muang

27607

Research Site, Raleigh

29340

Research Site, Gaffney

30990

Research Site, Ipoh

31200

Research Site, Chihuahua City

31326

Research Site, Rincon

32605

Research Site, Gainesville

32825

Research Site, Orlando

33175

Research Site, Miami

33606

Research Site, Tampa

33765

Research Site, Clearwater

34020

Research Site, Istanbul

34722

Research Site, Istanbul

35110

Research Site, Izmir

35660

Research Site, Sheffield

35965

Research Site, Izmir

38030

Research Site, Kayseri

40002

Research Site, Khon Kaen

42415

Research Site, Daegu

43016

Research Site, Dublin

44033

Research Site, Ulsan

45138

Research Site, Zapopan

50200

Research Site, Chiang Mai

50586

Research Site, Kuala Lumpur

54907

Research Site, Jeonju

60607

Research Site, Chicago

62290

Research Site, Cuernavaca

63141

Research Site, St Louis

63301

Research Site, Saint Charles

64465

Research Site, Monterrey

70000

Research Site, Hochiminh

78006

Research Site, Boerne

79912

Research Site, El Paso

90110

Research Site, Hat Yai

97202

Research Site, Portland

97504

Research Site, Medford

100000

Research Site, Hà Nội

180000

Research Site, Haiphong

202002

Research Site, Aligarh

208002

Research Site, Kanpur

302039

Research Site, Jaipur

305001

Research Site, Ajmer

395009

Research Site, Surat

550000

Research Site, Da Nang

641028

Research Site, Coimbatore

700000

Research Site, Ho Chi Minh City

900000

Research Site, Can Tho

C1414AIF

Research Site, Buenos Aires

C1425BEN

Research Site, Buenos Aires

B1878FNR

Research Site, Quilmes

B1646EBJ

Research Site, San Fernando

B2N 1L2

Research Site, Truro

L7N 3V2

Research Site, Burlington

N1H 6J2

Research Site, Guelph

G1W 4R4

Research Site, Québec

J6E 2B4

Research Site, Saint-Charles-Borromée

03650

Research Site, Benito Juárez

15-044

Research Site, Bialystok

26-060

Research Site, Chęciny

20-601

Research Site, Lublin

04763

Research Site, Seoul

06591

Research Site, Seoul

06620

Research Site, Ankara

03400

Research Site, Dinar

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY